Hot Off the Press: The DCB Annual Report 2023/24 is Out!

Hot Off the Press: The DCB Annual Report 2023/24 is Out!

Hot Off the Press: The DCB Annual Report 2023/24 is Out!

The fiscal year 2023/24 was a year marked by major milestones and remarkable progress for the Diabetes Center Berne (DCB), thanks to the great commitment of all employees. The DCB Annual Report has now been published and you can read more about the projects, teams, and their achievements of 2023/24.

The DCB – An Internationally Recognised Centre for Diabetes Technology

DCB is proud to have successfully completed their first large-scale projects. One highlight is the third edition of the Open Innovation Challenge 2023, which took their total number of partnerships with start-ups to around 100 start-ups from over 30 different countries.

Furthermore, Professor Lilian Witthauer and her team in the field of smart sensing along with Professor José Garcia-Tirado in the field of closed-loop systems are working on projects to improve the lives of people with diabetes. These initiatives exemplify how DCB effectively translates research findings into practical applications. Since April 2024, Professor Lisa Koch has also joined DCB, bringing her expertise in data analysis and artificial intelligence.

Special thanks go to the Advisory Board and patron Willy Michel, whose support enables DCB to position itself as an international center of excellence in diabetes technology.

Download the full report now!

Download the full report now!

Sign up for our newsletter
to receive the latest news.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Schweiz

DCB featured in Nature Portfolio: “Cutting-edge diabetes technology to make lives easier”

DCB featured in Nature Portfolio: “Cutting-edge diabetes technology to make lives easier”

DCB featured in Nature Portfolio: “Cutting-edge diabetes technology to make lives easier”

DCB is thrilled to be featured in the Nature Portfolio Spotlight on Switzerland. The article “Cutting-edge diabetes technology to make lives easier” dives into our work at DCB and outlines significant advancements in diabetes management.

Cutting-edge diabetes technology to make lives easier

The renowned Nature Portfolio has issued a Spotlight on Switzerland with the motto: “Switzerland has enjoyed a warm relationship with the rest of Europe for decades – but how has that influenced the research done in the country?”

DCB is thrilled to be featured in this Spotlight, shining a light on diabetes technology research and innovation.

Our assistant professors José García-Tirado and Lilian Witthauer, as well as our scientific program manager Martina Rothenbühler were interviewed, providing insights into their work at DCB and the development of technologies such as the artificial pancreas, which promises to transform the daily lives of people with diabetes by simplifying insulin management.

“Our mission is to support diabetes research and technological advancement. We’re building bridges between research and startups, industry and other stakeholders.”

– Martina Rothenbühler, DCB

Read the article now to dive deeper into our work and see how innovative technologies are shaping the future of diabetes management.

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Barcelona is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter
to receive the latest news.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Schweiz

The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

The DCB Open Innovation Challenge is Back: Submit Your Idea Now!

For the fourth time, the Diabetes Center Berne is launching the Open Innovation Challenge with the aim of specifically promoting innovative projects in the field of diabetes management on Swiss and international level. Participating innovtors benefit from professional expert feedback, and the six best projects receive access to a bootcamp. The finalists will receive prize money of up to USD 100,000 and further support from the DCB. The DCB Innovation Challenge is the world’s largest diabetes technology award with international appeal.

Can Your Idea Change Diabetes Management?

More than 537 million people worldwide live with diabetes, which means a constant challenge in everyday life for those affected. Technological innovations make an important contribution to making it easier to deal with diabetes – whether it is measuring glucose levels, planning the amount of insulin needed via an app or even using automated insulin delivery systems. But despite these enormous advances in diabetes technology, there is still a great, unmet need for innovative technical solutions. These should help to ease the challenge for users in everyday life and improve the lives of people with diabetes in the long term.

The DCB Open Innovation Challenge was initiated in 2021 with the aim of closing these gaps in diabetes technology with translational research. The goal of the challenge is to identify unique solutions which can make life easier for people with diabetes. Whether you’re a researcher, healthcare professional, start-up founder, or someone living with diabetes, your ideas are invaluable to us. We’re seeking diverse perspectives and innovative solutions to enhance the quality of life for individuals with diabetes.

 

What’s in it for you?

After a first round and feedback from the expert jury, the top 20 will enter a mentoring program. Two US-based innovators and four innovators from the rest of the world will be invited to an individually tailored bootcamp in the picturesque Swiss alps and will then pitch their final ideas at the grand DCB Start-Up Night in Berne, Switzerland, on 3 October 2024. Additionally, all finalists have the opportunity to present their ideas at the Diabetes Technology Meeting in the US on 15–17 October 2024.​

The winning project will be selected by an international expert jury and rewarded with USD 100,000 in funding and in-kind support – making the DCB Open Innovation Challenge the world’s largest diabetes technology award with international appeal. You will get access to a global network of experts from the field – all while your idea remains entirely yours.

Don’t miss out on this unparalleled opportunity to turn your idea into reality. Submit your idea by April 30 at our innovation platform innovation.dcberne.com

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Barcelona is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter
to receive the latest news.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Schweiz

Lisa Koch joins DCB as professor specialising in artificial intelligence and data science

Lisa Koch joins DCB as professor specialising in artificial intelligence and data science

Lisa Koch joins DCB as professor specialising in artificial intelligence and data science

The newly created assistant professorship with tenure track is the third of a total of three professorships in the field of “Diabetes Technology and Artificial Pancreas” jointly created by the University of Bern, the Inselgruppe and the Diabetes Center Berne (DCB).

Background in developing data science products for medical devices

Before taking up her new position, Lisa Koch worked on machine learning for biomedical data analysis. She has a background in academic research as well as developing data science products for medical devices, with a strong focus on technology that can ultimately benefit people’s health in a safe and trustworthy way.

After an undergraduate degree in electrical (BSc) and biomedical engineering (MSc) at ETH Zürich, Switzerland, Lisa Koch did a PhD in machine learning for medical image analysis at Imperial College London, UK.  After a post-doc at ETH Zürich, she joined the Swiss wearable medical device startup Ava, where she eventually became the data science team lead. In this position, she came to appreciate the need for demonstrably safe machine learning in healthcare.

Safe, reliable, and effective data science tools
In 2021, Lisa Koch returned to academic research to pursue research on this topic as a group leader for machine learning in medical diagnostics at the Hertie Institute for AI in Brain Health at the University of Tübingen, Germany. In her new role as assistant professor at the University of Bern, her long-term goal is to develop certifiably safe, reliable, and effective data science tools for patient-specific treatment systems in diabetes care.

“With my research, I strive to deliver trustworthy AI-enabled diabetes care that provides real benefit to patients and clinicians. I am thrilled to join the cross-disciplinary ecosystem at the Diabetes Center Berne and the University of Bern Clinic for Diabetology, Endocrinology, Nutritional Medicine and Metabolism (UDEM), an ideal environment to advance this vision” says Koch.

Derek Brandt, CEO of the DCB adds: “In addition to Lilian Witthauer, professor in the field of sensor technology, and José Garcia Tirado, professor for technology-assisted precision medicine, we have taken a third and important step with Professor Koch for the topic of artificial intelligence (AI) and data science in diabetes care. This enables us to further strengthen our international pioneering role in the field of translational diabetes technology research. We will continue doing everything we can to improve daily life for people with diabetes”.

Lisa Koch

Downloads

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Barcelona is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter
to receive the latest news.

* Pflichtfelder
DSGVO *

Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

Diabetes Center Berne and Diabetes Technology Society Collaborate for the 2024 DCB Open Innovation Challenge

We are very excited to announce the launch of the 2024 DCB Open Innovation Challenge for 1 April 2024, this year in collaboration with the Diabetes Technology Society!

Can Your Idea Change Diabetes Management Forever?

We are excited to announce the collaboration of the Diabetes Center Berne and the Diabetes Technology Society for the 2024 DCB Open Innovation Challenge, launching on 1 April 2024.​

The DCB Open Innovation Challenge was initiated in 2021 and is the largest innovation challenge in the field of diabetes technology. The goal of the challenge is to identify unique solutions which can make life easier for people with diabetes. Anyone with an idea can apply – whether researcher, healthcare professional, start-up or person living with diabetes. We want to hear from you!​

In 2024, two US-based innovators and four innovators from the rest of the world will be selected to pitch their final ideas at the grand DCB Start-Up Night in Berne, Switzerland, on 3 October 2024. Additionally, all finalists have the opportunity to present their ideas at the Diabetes Technology Meeting in the US on 15–17 October 2024.​ ​

Save the dates and seize the opportunity to watch your idea become reality: www.dcberne.com/en/innovation-challenge

More recent news

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Barcelona is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter
to receive the latest news.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Schweiz

“Day of the Sick” 2024 – Diabetes Centre Berne host of President Amherd’s speech 

“Day of the Sick” 2024 – Diabetes Centre Berne host of President Amherd’s speech 

“Day of the Sick” 2024 – Diabetes Centre Berne host of President Amherd’s speech 

Bern, 4 March 2024 – Yesterday was the 85th anniversary of Switzerland’s oldest Disease Awareness Day, the “Day of the Sick”. The aim is to raise public awareness of health and disease issues. The President of the Swiss Confederation gives a speech at this event, which this year was held at the Diabetes Centre Berne (DCB).

“Strengthening confidence” is the motto of this year’s “Day of the Sick”. In connection with this and as a strong player in innovation and research in the field of diabetes technology, the Diabetes Center Berne had the honour of hosting this year’s speech by the President of the Swiss Confederation, Viola Amherd. Supplemented by two statements from the DCB, from the perspective of people with diabetes, the President addressed the influence of collaboration and innovative technologies as well as the situation of carers and patients. 

“I had to prick my finger around 60,000 times to measure my blood sugar level. You can still see the traces of this on my fingertips today. Now I have a sensor on my arm that continuously measures my blood glucose level. This technological innovation has not only given me back valuable time, but also a lot of quality of life,” summarises Maren Schinz, Innovation Manager at the DCB, who has type I diabetes. 

The CEO of the DCB, Derek Brandt, adds: “Here at the Diabetes Centre Berne, we exchange ideas and develop new technologies. Our aim is to use new approaches to give people with diabetes back their freedom so that other areas of their lives can be given more space again.” 

Watch the recording now:

About DCB 
The Diabetes Center Berne (DCB) is a private, independent Swiss foundation established in 2017 with the aim of making life with diabetes easier. DCB supports ideas and projects in the field of diabetes technology worldwide by providing expertise, access to clinical research facilities and its own laboratories as well as financial resources. The aim is to work in partnership to bring them a big step closer to market entry. The work of the DCB is not profit-orientated – the goal is new findings and innovations in diabetes management as well as a lively community. 

 

About “Day of the Sick” 
The “Day of the Sick” is a non-profit organisation that was founded in 1939. Its members include patient organisations as well as health leagues, industry and professional associations, the Swiss Conference of Cantonal Health Directors (GDK) and other associations and federations active in the healthcare sector.  
Once a year, the “Day of the Sick” sensitises the population to a special topic in the area of health and illness. It aims to help promote relationships between the sick and the healthy, create understanding for the needs of the sick and remind people of the duties of the healthy towards the sick. It is also committed to recognising the activities of all those who work professionally and privately on behalf of patients and the sick. 

Media Contacts

Diabetes Center Berne

 

Freiburgstrasse 3
CH-3010 Berne
www.dcberne.com

Media Contact

Sunjoy Mathieu
sunjoy.mathieu@dcberne.com

Office Day of the Sick

c/o Nicole Fivaz
Hangweg 22
CH-3125 Toffen
www.tagderkranken.ch

Media Contact

Nicole Fivaz
info@tagderkranken.ch

Meet us at ATTD!

Meet us at ATTD!

The ATTD congress in Barcelona is just around the corner and different members of the DCB team will be on-site. Meet...

Sign up for our newsletter
to receive the latest news.

* Pflichtfelder
DSGVO *

DCB Research AG

Freiburgstrasse 3
3010 Bern
Schweiz